Unjha Formulations Q2 Results
- BSE: 531762
- NSE: -
- ISIN: INE576D01015
- Sector: Biotechnology & Drugs
BSE
27.5
-0.17 (-0.61%)
-0.17 (-0.61%)Volume665.00
Updated: Mon 25 Nov, 2024 | 15:26:00
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Unjha Formulations Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 23 | Jun 23 | QoQ Comp |
|---|---|---|---|
| Total Revenue | 4.76 | 3.76 | -% |
| Selling/ General/ Admin Expenses Total | 0.13 | 0.13 | -% |
| Depreciation/ Amortization | 0.02 | 0.02 | -% |
| Other Operating Expenses Total | 0.48 | 0.40 | -% |
| Total Operating Expense | 4.89 | 3.57 | -% |
| Operating Income | -0.12 | 0.19 | -% |
| Net Income Before Taxes | -0.12 | 0.18 | -% |
| Net Income | -0.12 | 0.18 | -% |
| Diluted Normalized EPS | -0.26 | 0.40 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST - Markets
03Buy or sell: Ganesh Dongre recommends three stocks to buy Monday — Nov 25
3 min read06:49 AM IST